Pular para o conteúdo
Merck

Antioxidant responses and degradation of two antibiotic contaminants in Microcystis aeruginosa.

Ecotoxicology and environmental safety (2012-09-29)
Ying Liu, Yuntao Guan, Baoyu Gao, Qinyan Yue
RESUMO

Cyanobacteria may interact with antibiotic contaminants in aquatic environments, but the interaction effects and mechanisms remain unclear. In the present study, aqueous culture of Microcystis aeruginosa was exposed to 50ng/l-1μg/l of spiramycin and amoxicillin for seven days. The influences of antibiotics on the antioxidant system of M. aeruginosa and the degradation of antibiotics by M. aeruginosa were investigated. The activities of superoxide dismutase (SOD) in spiramycin-treated M. aeruginosa were stimulated by up to 2.2 folds, while the activities of peroxidase (POD) and catalase (CAT) were inhibited by spiramycin at test concentrations of 500ng/l-1μg/l, with a decrease of up to 71% and 76% compared to the control, respectively. The activities of SOD, POD and CAT in M. aeruginosa were stimulated by amoxicillin during the whole exposure period, with respective increases of up to 60%, 30% and 120% relative to the control. At test concentrations of 500ng/l-1μg/l, the higher MDA contents in spiramycin-treated M. aeruginosa indicated a higher toxicity of spiramycin than amoxicillin, possibly due to the accumulation of hydrogen peroxide caused by the inhibited activities of POD and CAT under exposure to spiramycin. The increase of glutathione content, the stimulation of glutathione S-transferase activity and the degradation of each antibiotic were observed in M. aeruginosa during the 7-day exposure. At the end of exposure, 12.5%-32.9% of spiramycin and 30.5%-33.6% of amoxicillin could be degraded by M. aeruginosa from the culture medium, indicating the ability of M. aeruginosa to eliminate coexisting contaminants via detoxification.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Spiramycin
Supelco
Spiramycin from Streptomyces sp., VETRANAL®, analytical standard, mixture of isomers
Spiramycin, European Pharmacopoeia (EP) Reference Standard